NeuroCOVID/NeuroPASC, RECOVER initiative, ALS Expanded Access, NeuroNEXT. Clinical trials and human subjects research in stroke, spinal cord injury, traumatic brain injury, neurorehabilitation, neuroimaging, neuromodulation, transcranial direct current stimulation, transcranial magnetic stimulation, transcutaneous spinal stimulation, peripheral nerve stimulation and devices. Other research interests: Health disparities, DEIA, rural health, community engagement and outreach.
Lumy Sawaki-Adams, M.D., Ph.D., is a Program Director for the Division of Clinical Research (DCR) in the National Institute of Neurological Disorders and Stroke (NINDS). Prior to joining DCR, she served as a Program Officer in the Division for Research Capacity Building at the National Institute of General Medical Sciences. Lumy came to NIH from the University of Kentucky where she was an Associate Professor and the Cardinal Hill Endowed Scholar in Neurorehabilitation Research. She has extensive expertise in neuromodulation and clinical trials to improve function and quality of life in people with severe neurologic impairments including stroke, spinal cord injury, traumatic brain injury, chronic pain and cerebral palsy. She completed her medical degree and residency in Physical Medicine and Rehabilitation in Brazil and her Ph.D. in clinical neurophysiology in Japan. She completed a post-doctoral fellowship at NINDS.